Works matching IS 07423071 AND DT 2019 AND VI 36 AND IP 12


Results: 33
    1

    Editorial Board.

    Published in:
    Diabetic Medicine, 2019, v. 36, n. 12, p. 1521, doi. 10.1111/dme.13757
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Addition of low‐dose liraglutide to insulin therapy is useful for glycaemic control during the peri‐operative period: effect of glucagon‐like peptide‐1 receptor agonist therapy on glycaemic control in patients undergoing cardiac surgery (GLOLIA study)

    Published in:
    Diabetic Medicine, 2019, v. 36, n. 12, p. 1621, doi. 10.1111/dme.14084
    By:
    • Makino, H.;
    • Tanaka, A.;
    • Asakura, K.;
    • Koezuka, R.;
    • Tochiya, M.;
    • Ohata, Y.;
    • Tamanaha, T.;
    • Son, C.;
    • Shimabara, Y.;
    • Fujita, T.;
    • Miyamoto, Y.;
    • Kobayashi, J.;
    • Hosoda, K.
    Publication type:
    Article
    21
    22

    Type 1 diabetes genetic risk score discriminates between monogenic and Type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population.

    Published in:
    Diabetic Medicine, 2019, v. 36, n. 12, p. 1694, doi. 10.1111/dme.14071
    By:
    • Yaghootkar, H.;
    • Abbasi, F.;
    • Ghaemi, N.;
    • Rabbani, A.;
    • Wakeling, M. N.;
    • Eshraghi, P.;
    • Enayati, S.;
    • Vakili, S.;
    • Heidari, S.;
    • Patel, K.;
    • Sayarifard, F.;
    • Borhan‐Dayani, S.;
    • McDonald, T. J.;
    • Ellard, S.;
    • Hattersley, A. T.;
    • Amoli, M. M.;
    • Vakili, R.;
    • Colclough, K.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Aims and Scope.

    Published in:
    Diabetic Medicine, 2019, v. 36, n. 12, p. 1520, doi. 10.1111/dme.13756
    Publication type:
    Article
    32

    Table of Contents 2.

    Published in:
    Diabetic Medicine, 2019, v. 36, n. 12, p. 1519, doi. 10.1111/dme.13755
    Publication type:
    Article
    33